The “maternal effect” on epilepsy risk: Analysis of familial epilepsies and reassessment of prior evidence by Owen, Pickrell
The “maternal effect” on epilepsy risk: analysis of familial epilepsies and reassessment of prior evidence
 
Running head: Epilepsy maternal effect
 




1Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
2Epilepsy Research Centre, Department of Medicine, University of Melbourne (Austin
Health), Heidelberg, VIC, Australia.
3Florey Institute of Neuroscience and Mental Health, Parkville VIC, Australia.
4Department of Human Genetics, Emory University, Atlanta, GA, USA.
5Departments of Epidemiology and Neurology, and the G. H. Sergievsky Center,
Columbia University; and Division of Translational Epidemiology, New York State Psychiatric
Institute, New York, NY, USA.
 




Prof. Ruth Ottman, Ph.D.
Columbia University
630 W. 168th Street, P&S Box 16







Running head characters: 24
Abstract word count: 249
Introduction word count: 234
Discussion word count: 1,564







Objective: Previous studies have observed that epilepsy risk is higher among offspring of affected women than
offspring of affected men. We tested whether this “maternal effect” was present in familial epilepsies, which are
enriched for genetic factors that contribute to epilepsy risk.
Methods: We assessed evidence of a maternal effect in a cohort of families containing ≥3 persons with epilepsy
using three methods: (1) “downward-looking” analysis, comparing the rate of epilepsy in offspring of affected
women versus men; (2) “upward-looking” analysis, comparing the rate of the epilepsy among mothers versus
fathers of affected individuals; (3) lineage analysis, comparing the the proportion of affected individuals with
family history of epilepsy on the maternal versus paternal side.
Results: Downward-looking analysis revealed no difference in epilepsy rates among offspring of affected
mothers versus fathers (prevalence ratio 1.0, 95% CI 0.8, 1.2). Upward-looking analysis revealed more affected
mothers than affected fathers; this effect was similar for affected and unaffected sibships (odds ratio 0.8, 95%
CI 0.5, 1.2) and was explained by a combination of differential fertility and participation rates. Lineage analysis
revealed no significant difference in the likelihood of maternal versus paternal family history of epilepsy.
Interpretation: We found no evidence of a maternal effect on epilepsy risk in this familial epilepsy cohort.
Confounding sex imbalances can create the appearance of a maternal effect in upward-looking analyses and
may have impacted prior studies. We discuss possible explanations for the lack of evidence, in familial
epilepsies, of the maternal effect observed in population-based studies.
INTRODUCTION
Epilepsy is a disorder with multiple and varied genetic contributions.1 Many previous studies have observed
that epilepsy risk is higher among offspring of affected women than offspring of affected men.2–5 Many
explanations for this “maternal effect” have been considered, including genetic mechanisms (X-linked
inheritance, mitochondrial inheritance, epigenetic parent-of-origin effects), environmental exposures (maternal
seizures or anti-epileptic drugs during pregnancy), and methodologic biases.  However, none of these possible
explanations fully accounts for the observed maternal effect in common epilepsies,2,3 and the cause of this
observation remains unknown.
 Evidence of a maternal effect has come from several different types of analysis (Figure 1): (1)
comparison of the prevalence of epilepsy in the offspring of women versus offspring of men with epilepsy (i.e.,
“downward-looking” analysis); (2) comparison of the prevalence of epilepsy in the mothers versus fathers of
people with epilepsy (“upward-looking”); and (3) analysis of the the proportion of affected individuals with a
family history of epilepsy on the maternal vs. the paternal side of the pedigree (“lineage analysis”).
 In this study, we analyzed a cohort of familial epilepsies for evidence of a maternal effect, using each of
the approaches described above. A familial cohort is particularly useful for this analysis because it provides
large sample sizes of affected relatives, in contrast to population-based epidemiology studies. We also
reassessed prior studies that utilized upward-looking analyses, accounting for confounding sex biases that may




Ascertainment and data collection of the Epi4K familial epilepsy cohort have been described in detail
elsewhere.6,7 Briefly, families contained three or more relatives with recurrent unprovoked seizures. Known
acquired causes of epilepsy were excluded. Ascertainment occurred at seven centers in North America, Europe,
Australia and New Zealand. Comprehensive phenotypic data were collected about every affected individual
through diagnostic interviews and review of medical records, EEG and imaging reports. Data were reviewed to
ensure consistency of methods across sites and were synthesized by an expert clinician into electro-clinical
phenotypes. The multi-generational pedigrees obtained during this data collection process were the primary
basis of the current analyses.
 Families were classified as “generalized” if every affected individual had generalized (or unclassified)
epilepsy; as “focal” if every affected individual had focal (or unclassified) epilepsy; as “mixed” if both
generalized and focal phenotypes were present in separate individuals or in one person; and as “genetic epilepsy
with febrile seizures plus (GEFS+)” if at least one individual was classified as having the FS+ phenotype and at
least one other individual had either FS or FS+.6 Because individuals with structural brain lesions or moderate-
or-greater intellectual disability were excluded from the study, the generalized families consisted largely of
genetic generalized epilepsies and the focal families largely of non-lesional focal epilepsies. A few families in
this cohort have been included in previously published familial epilepsy cohorts.4,8
 The Epi4K study was approved by the research ethics committee at each participating site and all
subjects provided informed consent to participate. The current analysis used only deidentified data from that
study; therefore separate ethics approval was not required.
 
2. Downward-looking analysis
This analysis tested the hypothesis that the prevalence of a history of epilepsy was higher in offspring of
affected women than in offspring of affected men. For each affected individual in our cohort, we determined the
total number of affected offspring and number of affected offspring. Monozygotic twins were counted as one
offspring (n = 6 pairs). There were no discordant monozygotic twin pairs in this cohort. Nuclear families in
which both parents had epilepsy (n = 8 parent pairs) were excluded from this analysis
 Statistical analysis: The prevalence ratio (PR) was calculated for offspring of affected women relative to
offspring of affected men. Confidence intervals were calculated using bootstrap resampling procedures to
account for possible within-family correlation of observations. The null hypothesis was equal epilepsy




This analysis tested the following hypothesis: among the parents of affected individuals, the prevalence of a
history of epilepsy in mothers compared to fathers is higher than expected by chance. The unit of analysis was
sibships, defined as a group of siblings with the same mother and father. This avoids counting the same parent
multiple times if there were multiple affected siblings. Each sibship was classified as affected if one or more
of/span>its members had epilepsy, and as unaffected in none of its members had epilepsy. For half-sibships, the
shared parent was counted once while the unshared parents were each counted separately. The 8 sibships in
which both parents were affected were excluded from this analysis.
 Statistical analysis: We determined the ratio of affected mothers to affected fathers in affected sibships,
and compared this to the same ratio in unaffected sibships. Unaffected sibships are an appropriate control group
because they reveal the likelihood of observing epilepsy in mothers versus fathers in this cohort due to chance,
independent of whether epilepsy is transmitted to offspring. Odds ratios (OR) and 95% confidence intervals
were calculated for the comparison of affected versus unaffected sibships. Odds ratios were used here because
the outcome of interest was the odds that an affected parent was female vs. male, whereas in the downward-
looking analysis prevalence ratios were used because the outcome of interest was the prevalence of epilepsy
among sets of offspring. The null hypothesis was that the ratio of affected mothers to affected fathers was the




For affected sibships with neither parent affected, we examined the epilepsy histories of second-degree relatives
(grandparents and aunts/uncles). If any of these relatives was affected, the sibship was coded as having a family
history of epilepsy on the maternal side or the paternal side, depending on the unaffected parent through whom
the sibship was related to the affected second-degree relative. Five sibships with affected relatives on both
parents’ sides were excluded from this analysis. We tested the hypothesis of more sibships with maternal family
history than paternal family history.
 Statistical analysis: A binomial probability test was used to compare the observed proportion of sibships
with maternal vs. paternal family histories to the null hypothesis of equal proportions (0.5). Subgroup analyses
were not performed due to small sample sizes.
 
5. Statistical analysis
Statistical analyses were performed in the R programming language, using packages Kinship2, FamAgg,




A complete description of this cohort of familial epilepsies has been previously reported.6
The cohort contained 1,120 individuals with epilepsy from 303 families: 117 families with only generalized
epilepsy (417 affected individuals), 62 families with only focal epilepsy (220 individuals), 102 mixed families
manifesting both generalized and focal epilepsies (387 individuals), and 22 GEFS+ families (96 individuals).
Of the pedigrees used in this analysis, 280/303 (92%) spanned three or more generations. Among people with
epilepsy in the cohort,  57% were female.
 
2. Downward-looking analysis
Among offspring of affected individuals, prevalence of a history of epilepsy did not differ in offspring of
affected women compared to offspring of affected men ( Figure 2 ). This was true in the cohort overall and in
each familial epilepsy type. There were also no differences among the specific epilepsy syndromes within the
generalized or focal families (data not shown). We emphasize that the offspring epilepsy rates observed in this
highly selected cohort of familial epilepsies do not reflect offspring risk in the general population.
 
3. Upward-looking analysis
Among affected sibships we observed more affected mothers than affected fathers ( Figure 3 ). This was true in
the cohort overall and in each familial epilepsy type except for GEFS+. Rather than compare these values to a
null hypothesis of 50% affected mothers, we used unaffected sibships as a control group. Among unaffected
sibships, we also observed more affected mothers than affected fathers. Comparison of affected versus
unaffected sibships revealed no statistically significant differences in the odds that an affected parent was the
mother vs. the father. Results were similar when stratified by specific epilepsy syndromes within generalized
and focal families (data not shown).
 We next explored possible reasons for the enrichment of affected mothers compared to affected fathers,
observed in both affected and unaffected sibships. In our cohort, there were 1.8-times as many affected women
who were mothers as affected men who were fathers (255 vs 141). Put another way, ifsibship with an affected
parent is chosen at random from this cohort, the odds are 1.8 (or a 64% chance) that the affected parent is the
mother, regardless of whether the sibship is affected or unaffected.
 This enrichment of affected mothers resulted from a combination of two independent sex imbalances.
First, there were more affected female than male subjects with epilepsy overall (57% female; F:M ratio = 1.3).
Second, the likelihood that an affected subject was a parent (i.e., had  1 offspring) was higher for affected
female than for affected male subjects (40% vs 29%, F:M ratio = 1.4). Multiplying these two ratios (1.3 x 1.4)
yields the observed 1.8-fold enrichment in affected mothers. These observations fully account for the findings
of our upward-looking analysis.
 
4. Lineage analysis
Among 474 affected sibships with neither parent affected, 83 had a family history of epilepsy in at least one
second-degree relative (grandparent or aunt/uncle).  This family history was on the maternal side in 46 and on
the paternal side in 37, which was not significantly different from chance (p = 0.38).
 
DISCUSSION
We did not find evidence of a maternal effect in this familial epilepsy cohort. Downward-looking analysis
revealed similar prevalence of a history of epilepsy among offspring of affected mothers compared to offspring
of affected fathers. Upward-looking analysis revealed more affected mothers than affected fathers; this effect
was similar for affected and unaffected sibships, and was explained by other confounding sex imbalances.
Lineage analysis revealed no significant difference in the likelikhood of family history on the maternal versus
the paternal side of the pedigrees.
 
Downward-looking analysis
Most previous studies that utilized downward-looking analyses have found higher rates of epilepsy in offspring
of affected women than affected men (Supplementary Table 2). In contrast to the upward-looking approach,
the discrepancy between our study and prior downward-looking studies is not readily explained by our analysis.
We do not refute the observations of those studies, and a true maternal effect may exist in cohorts other than the
one studied here, as discussed below.
 The strongest evidence for a maternal effect comes from the Rochester Epidemiology Project, a
population-based sample of residents of Olmsted County, Minnesota.3,9–11 Annegers et al. (1976) observed
epilepsy in 10/351 (2.8%) offspring of affected women and in 0/229 (0%) offspring of affected men.9 In a later
study of this cohort, Peljto et al. (2014) observed epilepsy in 14/355 (3.9%) offspring of affected women and
4/279 (1.4%) offspring of affected men.10 This maternal effect was present only for offspring of parents with
focal epilepsy (7/210 vs. 1/152) and not for those with generalized epilepsy (5/82 vs. 3/60). Othr studies have
observed a maternal effect in generalized epilepsies.12 Studies of the Rochester data observed a low epilepsy
risk in offspring of affected men, similar to the baseline population risk. However, the numbers of affected
offspring in the Rochester studies were small, and the findings warrant confirmation in an independent
population-based study. Preliminary analyses of offspring risks from the large Danish population registry are
also consistent with a maternal effect (Jakob Christensen, personal communication).
 
Upward-looking analysis
Most prior studies that utilized upward-looking analyses have observed more affected mothers than affected
fathers. Several studies have reported a statistically significant difference when compared to a null hypothesis
of equal proportions affected mothers and fathers.4,5,12 However, our results demonstrate that these analyses are
affected by two important confounders, namely (1) differences in the proportions of women and men in the
cohort (here, more women than men) and (2) higher likelihood of parenthood for women than for men with
epilepsy. Each of these sex imbalances, if present in a cohort, will affect the ratio of affected mothers to fathers
with epilepsy.
 We used unaffected sibships as a control group. Other studies have also observed more mothers than
fathers with epilepsy among the parents of unaffected control groups,13–15 although the cause of this imbalance
has not been demonstrated until now. We suspect that previous studies reporting a maternal effect on the basis
of upward-looking analyses were affected by the same biases present in our data. Indeed, in our own data the
ratio of affected mothers to fathers would have appeared statistically significant in all families and in the subset
of generalized families had we tested (incorrectly) against a null hypothesis of equal numbers of mothers and
fathers.
 Women with epilepsy are more likely to marry and to become parents compared to men with epilepsy
(Supplementary Table 3). In our cohort, women with epilepsy were 1.4-times more likely than men to have
any offspring, consistent with prior evidence. The imbalance in parenthood rates between women and men with
epilepsy must be accounted for in any upward-looking analysis of maternal transmission of epilepsy risk.
 On the basis of the two confounding sex imbalances (sex ratio and parenthood ratio) identified in our
data, we reassessed previous studies that utilized upward-looking analyses (Supplementary Table 4). Most
studies reported the numbers of female and male subjects, but none reported parenthood rates. Assuming a
parenthood ratio of 1.4 based on the evidence presented above, we calculated for each study the expected ratio
of affected mothers to affected fathers, similar to the approach of Ottman et al (1985).2 Under the assumptions
of this reassessment, none of the previous studies demonstrated a statistically significant increase in affected
mothers above the expected value.
 
Lineage analysis.
Five previous studies have conducted similar analyses.5,12,16–18 All have reported that family history of epilepsy
more commonly occurred on the maternal side than the paternal side, and this difference was statistically
significant in two studies.12,16 In our data there was no difference in the likelihood of maternal versus paternal
family history of epilepsy. This analysis is not subject to the same biases as the upward-looking analysis
because the sex of the affected second-degree relatives is not considered. However, reporting bias is a concern,
as mothers may be more likely to provide family histories and to know their own family history better than their
partner’s. Several studies have observed more maternal than paternal family histories of epilepsy in unaffected
control subjects, consistent with reporting bias.14,15 Our dataset did not allow us to perform lineage analysis on
unaffected sibships.  
 
Is a maternal effect confined to certain cohorts?
The possible biological and methodological causes of the maternal effect have been extensively discussed, with
no single explanation fully explaining the observed data.2 Of special interest here is why this effect is not
present in our study nor in one previous study of familial epilepsies.8 Are there explanations for a maternal
effect present in unselected epilepsy cases but not in families ascertained through multiple affected individuals?
 One possibility is that the distribution of causal genetic and nongenetic factors is different in the
families analyzed here than in the general population. Our data collection strategy was specifically designed to
enrich the sample for genetic causes of epilepsy, whether involving rare variants of large effect or combinations
of common variants of smaller effect. If the maternal effect is due to another type of mechanism underlying risk
in the general population, this enrichment for genetic causes might have made it more difficult to detect in the
families we studied.
 “Selective fertility” is another possible explanation for the maternal effect.2,10 If people with genetic
forms of epilepsy have reduced fertility compared to people with non-genetic forms of epilepsy, then given that
fertility reductions are greater in men than in women with epilepsy, offspring of affected men will come
disproportionately from men with non-genetic epilepsies (compared with offspring of affected women), and
relatively fewer of their offspring will inherit the disorder. Epilepsies in our familial epilepsy cohort can be
presumed to be strongly influenced by genetic factors, and so this selective fertility might be present in the
population but not in our cohort. One previous study explicitly tested this hypothesis and found that men with
epilepsy who had a family history of epilepsy did not have reduced fertility compared to men without a family
history;19 however, additional studies are needed.
 Environmental exposures during fetal development, such as maternal seizures or anti-epileptic drugs,
could lead to increased epilepsy risk in the offspring of affected mothers. These factors might play a larger role
in sporadic cases and a smaller role in familial cases where the influence of genetics is stronger. However, these
hypotheses have been tested and did not explain the maternal effect in population studies.3,9,11 Anti-epileptic
drugs did not increase risk in offspring; maternal seizures during pregnancy were associated with increased risk
in offspring, but the maternal effect persisted after adjusting for this variable.3
 Finally, ascertainment biases are likely to differ across methodologies, and are particularly relevant to
studies of multiplex families, which over-sample individuals with affected offspring or parents relative to their
occurrence in the general population. If for some reason this oversampling were more pronounced for men than




We studied a selected cohort of families containing multiple individuals with epilepsy. Such a cohort is useful
for analysis of the genetic architecture of familial epilepsies, but this is not an epidemiologic study. In
particular, theates of epilepsy in offspring in these families are greatly inflated -- 10-times higher than the risk
to offspring of unselected persons with epilepsy.10 Second, our data were based on interviews, supplemented
with medical records and additional family informants when possible, but are still subject to the inaccuracies
and potential biases of subjects’ reports. Third, data on unaffected individuals were limited, particularly for
branches of the pedigrees without any affected individuals, which precluded some analyses.
 
Conclusions
We did not find evidence of a maternal effect on epilepsy risk in a cohort of familial epilepsies, using three
different methods of analysis. Imbalances in sex ratio and parenthood ratio can confound upward-looking
analyses and may explain the findings of previous studies that utilized this approach. Our data do not refute
previous downward-looking analyses in population-based studies. It remains to be determined why the maternal
effect seen in those studies is not evident in familial epilepsies.  To clarify the reasons for these findings, the
most informative analyses would compare, within a single dataset, offspring risks and fertility rates for
probands with epilepsy with and without a family history of epilepsy in parents and siblings. Such an analysis
would require a population-based dataset that is large enough to yield sufficient power and systematically
ascertained, so that selection bias can be avoided.   
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FIGURE LEGENDS
 
Figure 1. Methods of observing maternal transmission of epilepsy risk. (A) Downward-looking analysis,
comparing the prevalence of a history of epilepsy in offspring of affected women versus men; (B) Upward-
looking analysis, comparing the prevalence of a history of the epilepsy among mothers versus fathers of
affected individuals; (C) Lineage analysis, comparing family history of epilepsy on the maternal side vs. the
paternal side of the pedigree.
 
Figure 2. Results of downward-looking analysis
Prevalence of a history of epilepsy among offspring of affected mothers versus offspring of affected fathers.
Abbreviations: GEFS+, genetic epilepsy with febrile seizures plus; PR, prevalence ratio (offspring of affected
mothers relative to fathers).
 
Figure 3. Results of upward-looking analysis
Prevalence of a history of epilepsy among mothers versus fathers of subjects with epilepsy.
Abbreviations: F, female; M, male; OR, odds ratio (affected sibships relative to unaffected sibships); GEFS+,
genetic epilepsy with febrile seizures plus.
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Results of downward-looking analysis. Rate of epilepsy among offspring of
affected mothers versus offspring of affected fathers. Abbreviations: GEFS+,
genetic epilepsy with febrile seizures plus; PR, prevalence ratio (offspring of
affected mothers relative to fathers). 
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Results of upward-looking analysis. Rate of epilepsy among mothers versus
fathers of subjects with epilepsy. Abbreviations: F, female; M, male; OR, odds
ratio (affected sibships relative to unaffected sibships); GEFS+, genetic epilepsy
with febrile seizures plus. 
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Supplementary Table 2. Studies utilizing downward-looking analyses
 





affected men PR (95% CI)
Current study Familial epilepsy Multiplex families 235/705 (33%) 136/389 (35%) 1.0 (0.8, 1.1)
8Afawi, 2016 Familial GGE Multiplex families 30/111 (26%) 15/48 (31%) 0.9 (0.5, 1.5)
10Peljto, 2014 Epilepsy Population 14/355 (3.9%) 4/279 (1.4%) 2.8 (0.9, 8.3)
3Ottman, 1988 Epilepsy Population 17/369 (3.9%) 6/318 (1.9%) 2.4 (1.0, 6.1)
20Janz, 1986 JME Clinic 3/59 (5.1%) 3/31 (9.7%) 0.5 (0.1, 2.5)
21Tsuboi, 1986 Epilepsy Clinic 16/443 (3.6%) 9/434 (2.1%) 1.7 (0.8, 3.9)
22Beck-Mannagetta,
1986
Epilepsy Clinic 26/453 (5.7%) 13/387 (3.4%) 1.7 (0.9, 3.3)
23Janz, 1982 Epilepsy Clinic 16/397 (4.0%) 10/371 (2.7%) 1.5 (0.7, 3.3)
11Annegers, 1978 Epilepsy Population 11/422 (2.6%) 2/265 (0.8%) 3.0 (0.7, 14)
24Tsuboi, 1977 Epilepsy Clinic 8/273 (2.9%) 4/233 (1.7%) 1.7 (0.5, 5.6)
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9Annegers, 1976 Epilepsy Population 10/351 (2.8%) 0/229 (0%) N/A
12Tsuboi, 1973 JME Clinic 12/142 (8.5%) 2/133 (1.5%) 5.6 (1.3, 24)
25Echeverria, 1880
Married
epileptics Not reported 57/298 (19%) 21/255 (8%) 2.3 (1.4, 3.7)
Abbreviations: GGE, genetic generalized epilepsy; JME, juvenile myoclonic epilepsy; PR, prevalence ratio.
 
Comments
Several studies utilized data from the Rochester Epidemiology Project and their cohorts overlap: Peljto et al. (2014), Ottman et al.
(1988), Annegers et al. (1978), Annegers et al. (1976). There is likely overlap in the cohorts of Beck-Mannagetta et al. (1986)
and Janz et al. (1982). There is likely overlap in the cohorts of Tsuboi (1986), Tsuboi & Christian (1977), and Tsuboi & Endo
(1973).
Supplementary Table 3. Parenthood and marriage rates for women versus men with epilepsy.
 
A. Parenthood rates  Parenthood Rate, N (%)  
Study Cohort Location Women Men OR
Current study Familial epilepsy USA/Eur/AU/NZ 263/637 (41%) 149/483 (31%) 1.4
26Starck, 2019 Childhood onset epilepsy Finland 59/143 (41%) 40/164 (24%) 1.7
27Schupf, 1994 Idiopathic epilepsy USA 586/960 (61%) 232/586 (40%) 1.5
Median OR     1.5
      
B. Marriage rates  Marriage Rate, N (%)  
Study Cohort  Women Men OR
21Tsuboi, 1986 Epilepsy Japan 305/440 (69%) 257/484 (53%) 1.3
28Lindsay,1979 Temporal lobe epilepsy UK 25/37 (68%) 17/63 (27%) 2.5
29Dansky, 1980 Epilepsy Canada 61/100 (61%) 38/100 (38%) 1.6
30Wada, 2004 Epilepsy, normal intellect Japan 84/136 (62%) 76/142 (53%) 1.2
31Kim, 2010 Epilepsy, normal intellect Korea 202/308 (66%) 131/276 (47%) 1.4
26Starck, 2019 Childhood onset epilepsy Finland 50/143 (35%) 37/164 (23%) 1.5
Median OR     1.4
Abbreviations: OR, odds ratio
 
Comments
(A) Parenthood rate refers to the likelihood that an individual had  1 offspring. This is distinct from fertility, which is typically
expressed as number of offspring per person. (B) Marriage rates were examined as a surrogate measure of reproductive potential.
These studies are largely consistent, even across cultures, in demonstrating that women with epilepsy are more likely to marry
than men with epilepsy.
 
Supplementary Table 4. Studies utilizing upward-looking analyses
 
  Probands Affected Parents  
Study Cohort N SR F:M SR (95% CI)
Expected
SR
8Afawi, 2016 Familial GGE 179 1.7 45:15 3.0 (1.6, 5.8) 2.4
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5Pal, 2006 JME or EEG trait 89 2.7 22:4 5.5 (2.0, 15) 3.8
4Marini, 2004 Familial GGE 55 1.4 17:9 1.9 (0.9, 3.9) 2.0
32Doose, 2001 Absence and MAE 82 1.0 9:6 1.5 (0.6, 4.0) 1.4
17Doose, 1987 Absence and MAE 400 0.8 29:29 1.0 (0.6, 1.6) 1.1
16Doose, 1969 Photosensitive epilepsy 99 1.4 4:1 4.0 (0.5, 35) 2.0
20Janz, 1986 JME 181 1.3 4:4 1.0 (0.3, 3.9) 1.8
18Gerken, 1977 Focal epilepsy 203 0.6 6:3 2.0 (0.5, 7.7) 0.9
12Tsuboi, 1973 JME 319 1.0 15:6 2.5 (1.0, 6.4) 1.4
14Metrakos, 1960 Convulsions 63 NR 9:4 2.2 (0.7, 7.0) (1.4)
33Ounsted, 1952 Convulsions 327 NR 26:10 2.6 (1.3, 5.2) (1.4)
34Harvald, 1951 Epilepsy 1200 NR 28:26 1.1 (0.6, 1.8) (1.4)
13Stein, 1933 Epilepsy 1000 1.1 35:23 1.5 (0.9, 2.6) 1.5
35Clarke, 1880a Epileptic prisoners 119 0.34a 17:8 2.1 (1.0, 4.7) (1.4)
25Echeverria, 1880 Married epileptics 136 1.2 10:8 1.2 (0.5, 3.1) 1.7
Abbreviations: GGE, genetic generalized epilepsy; JME, juvenile myoclonic epilepsy; MAE, myoclonic-atonic epilepsy; SR =
Sex Ratio, females to males
aClarke (1880) sex ratio reflects prison population, thus not used to calculate expected SR.
 
Comments
Expected sex ratio (SR) was calculated by multiplying the sex ratio reported in the study by the assumed parenthood ratio of 1.4.
This assumed parenthood ratio is based on evidence presented in Supplementary Table 2; see main text for discussion. As
demonstrated in our primary analysis, the combination of these two factors estimates the ratio of affected mothers to fathers that
is expected in the cohort due to chance alone. When a study did not report the sex ratio of its cohort, an expected SR value of 1.4
is shown in parentheses, representing the contribution of the assumed parenthood ratio. This reassessment demonstrates that the
expected value accurately predicts the observed value in many studies; in no study does the observed SR significantly differ from
the expected SR; and in nearly half (6/14) the observed value is less than or equal to the expected value. A few families in our
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